Previous Page  12 / 20 Next Page
Information
Show Menu
Previous Page 12 / 20 Next Page
Page Background

allied

academies

Virology Research Journal

Volume 1 Issue 4

Vaccines World 2017

Notes:

Page 44

November 09-10, 2017 Vienna, Austria

21

st

World Congress and Exhibition on

VACCINES, VACCINATION & IMMUNIZATION

Vaccines against infectious diseases

Ivana Haluskova Balter

French Society of Immunology, France

A

vaccine is a biological preparation that improves

immunity to a particular microorganism. Accurate

diagnostic and surveillance with better understanding

of genetic and immunologic background of host specific

response and pathogen evolution drives adapted vaccine

research. AMR (antimicrobial) resistance is regarded

nowadays as a major threat to global public health. The issue

is receiving high-level political attention (G7 summit and

upcoming G20 for first time). Pandemics, drug resistance and

neglected diseases framing health as a global security issue.

WHO made a list to promote research and development

(R&D) of new antibiotics (27th Feb 2017) underlining

gram-negative bacteria. Although initially omitted from

the list, tuberculosis and latent tuberculosis represent still

a major issue to tackle. XDR tuberculosis has evolved in

several tuberculosis endemic countries to drug incurable

or programmatically incurable tuberculosis. BCG vaccine

successfully helped to interrupt transmission cycle and along

with antibiotic discovery to decrease mortality. However, its

efficacy remains controversial. HIV/AIDS has known link

with tuberculosis but other risk factors have also emerged in

recent years as important determinants of the TB epidemic,

one of which is diabetes mellitus. Risk or new emerging and

re-emerging pathogens originated from animals after having

crossed the species barrier (e.g., Ebola) and re-appearance of

old diseases like pertussis, measles and known limitations of

drugs underline need for innovative vaccines as highly potent

tool to tackle resistance and valuable alternative from long

term perspective being clearly recognized as a major tool for

public health.

ivankahhaluskova@gmail.com

Virol Res J 2017, 1:4